Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Lund (Giessen, Germany), A. Yogeswaran (Giessen, Germany), K. Tello (Giessen, Germany), N. Sommer (Giessen, Germany), J. Grimminger (Giessen, Germany), L. Harbaum (Hamburg, Germany), J. Hennigs (Hamburg, Germany), H. Klose (Hamburg, Germany), H. Ghofrani (Giessen, Germany), W. Seeger (Giessen, Germany), M. Richter (Giessen, Germany), H. Gall (Giessen, Germany). Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker?. 1525

Member's Comments

No comment yet.

Related content which might interest you: Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? Source: Eur Respir J 2016; 48: 1265-1267 Year: 2016 Screening for biomarkers in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Thrombospondin-1 in pulmonary hypertension: A potential indicator of shearstress Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020 Year: 2020 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Parasympathetic activity in pulmonary arterial hypertension: could a simple measure do the trick? Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 HbA1c in pulmonary arterial hypertension – A marker of prognostic relevance? Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Simple, non-invasive methods to assess severity of pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007